Revvity (NYSE:RVTY) Price Target Cut to $96.00 by Analysts at JPMorgan Chase & Co.

Revvity (NYSE:RVTY) had its price objective reduced by JPMorgan Chase & Co. from $105.00 to $96.00 in a report published on Tuesday,Benzinga reports. They currently have a neutral rating on the stock.

Several other brokerages have also commented on RVTY. Wall Street Zen upgraded shares of Revvity from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Barclays lifted their price objective on shares of Revvity from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Tuesday, February 3rd. Robert W. Baird set a $129.00 target price on shares of Revvity in a research report on Tuesday, February 3rd. Wells Fargo & Company raised their target price on Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a report on Tuesday, February 3rd. Finally, TD Cowen reaffirmed a “hold” rating on shares of Revvity in a research report on Tuesday, February 3rd. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $112.92.

Revvity Trading Up 3.3%

Shares of NYSE RVTY opened at $87.56 on Tuesday. The business has a 50 day simple moving average of $97.12 and a 200 day simple moving average of $96.60. Revvity has a 52 week low of $81.36 and a 52 week high of $118.30. The stock has a market cap of $9.79 billion, a price-to-earnings ratio of 42.09, a PEG ratio of 1.80 and a beta of 1.10. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.40 and a current ratio of 1.68.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Monday, February 2nd. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.15. The firm had revenue of $772.06 million for the quarter, compared to analyst estimates of $759.81 million. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The company’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.42 earnings per share. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, research analysts predict that Revvity will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, April 17th. Revvity’s dividend payout ratio is currently 13.46%.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of RVTY. AQR Capital Management LLC boosted its holdings in Revvity by 5.2% during the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock valued at $883,000 after acquiring an additional 420 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Revvity by 6.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock worth $1,246,000 after purchasing an additional 744 shares during the period. Millennium Management LLC increased its stake in shares of Revvity by 102.0% in the first quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock worth $7,343,000 after purchasing an additional 35,048 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Revvity by 45.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock worth $64,232,000 after purchasing an additional 189,871 shares during the last quarter. Finally, Focus Partners Wealth lifted its position in shares of Revvity by 13.0% during the 1st quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock worth $744,000 after purchasing an additional 811 shares during the last quarter. Institutional investors own 86.65% of the company’s stock.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.